422 results on '"Tuccillo, C."'
Search Results
2. 73P Effect of combination therapy with atezolizumab plus metformin on peripheral immune cells from NSCLC patients
3. 16P Investigation of c-MYC role in DNA-PK-mediated activation of STING pathway in SCLC
4. 1810P MYC expression defines distinct transcriptomic landscape and affects response to DNA-damaging therapies in SCLC
5. 1800P Breaking chemo-immunotherapy resistance in SCLC-patient derived tumor with novel DDRi combinations
6. Role of bisphenol A as environmental factor in the promotion of non‐alcoholic fatty liver disease: in vitro and clinical study
7. Apple polyphenol extracts prevent damage to human gastric epithelial cells in vitro and to rat gastric mucosa in vivo
8. The global nutritional characterization of patients with non-alcoholic fatty liver disease: from factors that may influence their dietary intake to body composition: 905
9. OC.11.5 BONE MASS DENSITY AND RISK FRACTURE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: ROLE OF VITAMIN D AND OSTEOPROTEGERIN
10. T06.01.16 EVALUATION OF THE EFFECT DERIVED FROM SILYBIN WITH VITAMIN D AND 3 VITAMIN E ADMINISTRATION ON CLINICAL, METABOLIC, ENDOTHELIAL 4 DYSFUNCTION, OXIDATIVE STRESS PARAMETERS AND SEROLOGICAL WORSENING 5 MARKERS IN NON-ALCOHOLIC FATTY LIVER DISEASE PATIENTS
11. T02.01.9 EFFICACY OF 14-DAY CONCOMITANT THERAPY IN THE ERADICATION OF H. PYLORI INFECTION: COMPARISON WITH 10-DAY CONCOMITANT THERAPY
12. T06.01.9 THE BISPHENOL A INDUCED WORSENING OF NON-ALCOHOLIC FATTY LIVER DISEASE: A CLINICAL STRATEGY TO ANTAGONIZE THE PROGRESSION OF THE DISEASE
13. A new silybin-vitamin E-phospholipid complex improves insulin resistance and liver damage in patients with non-alcoholic fatty liver disease: preliminary observations
14. Non-alcoholic fatty liver disease: a multicentre clinical study by the Italian Association for the Study of the Liver
15. Liver p53 expression in patients with HCV-related chronic hepatitis
16. CHANGES IN THE OXIDATIVE PROFILE DURING COMBINATION THERAPY (IFNα-2b+RIBAVIRIN) IN CHRONIC HEPATITIS C
17. INDUCTION THERAPY WITH INTERFERON RADIPLY CLEARS SERUM HCV RNA
18. DIRECT RELATIONSHIP BETWEEN THE AMOUNT OF DAILY ETHANOL INTAKE AND HCV-RNA PLASMA LEVELS IN PATIENTS WITH HCV-RELATED CHRONIC HEPATITIS
19. LONG-TERM OUTCOME OF CHRONIC HEPATITIS C IN PATIENTS TREATED WITH INTERFERON
20. DIFFERENT DISTRIBUTION OF AMINOTRANSFERASE VALUES AMONG HEALTHY HCV CARRIERS IN RELATION TO PRESENCE/ABSENCE OF VIREMIA
21. RECOMBINANT vs LEUCOCYTIC INTERFERON IN THE TREATMENT OF HCV CHRONIC LIVER DISEASE: FINAL REPORT OF A RANDOMIZED CONTROLLED TRIAL
22. Up-regulation of heparin binding epidermal growth factor-like growth factor and amphiregulin expression in Helicobacter pylori-infected human gastric mucosa
23. C07/06 ENHANCED TURNOVER OF GLUTATHIONE DURING INTERFERON THERAPY OF PATIENTS WITH HCV-RELATED CHRONIC HEPATITIS
24. Interferon-related thyroid autoimmunity and long-term clinical outcome of chronic hepatitis C
25. Subjects positive for hepatitis C virus RNA with normal aminotransferase levels, a “trompe l'oeil” clinical picture?
26. Qualitative and quantitative evaluation of gut microbial populations in severely obese patients following bilio-intestinal bypass
27. Silybin–Phosphatidylcholine Complex Protects Human Gastric and Liver Cells from Oxidative Stress
28. Peptide Hp(2–20) accelerates healing of TNBS‐induced colitis in the rat
29. OC.16.2 EVALUATION OF UROTENSIN II RECEPTOR EXPRESSION IN PATIENTS WITH ULCERATIVE COLITIS
30. P.01.18 A REAL LIFE OBSERVATIONAL STUDY ON THE ERADICATION OF H. PYLORI INFECTION IN PATIENTS NAÏVE TO TREATMENT USING CONCOMITANT THERAPY OR BISMUTH QUADRUPLE THERAPY (THREE-IN-ONE PILL)
31. New Silibinin glyco-conjugates: Synthesis and evaluation of antioxidant properties
32. Healing of TNBS-Induced Colitis in the Rat by Peptide HP(2-20)
33. HCV infection and hepatocellular carcinoma in cirrhotics: What is the linkage?
34. P.09.8: Role of Bisphenol a as Environmental Factor in the Promotion of Non-Alcoholic Fatty Liver Disease: In VITRO and in VIVO Protective Effects of Silybin
35. Healing of TNBS-Induced Colitis in the Rat by Peptide HP(2-20)
36. PEPTIDE HP 2-20 ACCELERATED HEALING OF TNBS-INDUCED COLITIS IN THE RAT
37. Food intake, gastrointestinal hormones and intestinal permeability in patients with HCV-related chronic liver disease
38. Evaluation of serum levels of gastrointestinal hormones in obese patients before and after bariatric surgery
39. Urotensin-II receptor: a new marker for the differentiation and the target in colon cancer?
40. Apple polyphenols extract (APE) improves colon damage in a rat model of colitis
41. Nutritional evaluation and pattern of secreted gastrointestinal hormones in patients with diagnosis of non-alcoholic fatty liver disease (NAFLD)
42. Nonsteroidal Anti-Inflammatory Drugs inhibit VacA-induced Cell Vacuolation in vitro by Inhibiting Vacuole Genesis
43. Silybin conjugated with phosphatidilcholine and vitamin E improves liver damage in patients with NAFLD: the results of a randomized multicentre double-blind vs placebo trial
44. Gut microbiota and probiotics in chronic liver diseases
45. The global nutritional characterization of patients with non-alcoholic fatty liver disease: from factors that may influence their dietary intake to body composition
46. Antitumour efficacy of MEK inhibitors in human lung cancer cells and their derivatives with acquired resistance to different tyrosine kinase inhibitors
47. Effect of different alcoholic beverages on gastric epithelial cell: role of oxidative stress
48. Il recettore dell’ urotensina: un nuovo marker per il differenziamento ed il target nel cancro del colon?
49. Espressione del recettore dell’urotensina-II nell’adenocarcinoma del colon umano: studi in vitro ed in vivo
50. Valutazione dell’effetto di silibina+fosfatidilcolina+vitamina E vs placebo sul danno epatico in pazienti con NAFLD (nonalcoholic fatty liver disease): risultati di un trial clinico europeo randomizzato in doppio cieco
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.